New Jersey is the latest venue for consolidation of Yaz and Yasmin lawsuits. New Jersey’s Administrative Office of the Courts issued the consolidation order on February 18, 2010. The consolidation order is typically issued when a group of plaintiffs share the same basic set of facts and the same defendant(s).
Yaz and Yasmin lawsuits have continued to mount as women suffer serious side effects from taking the birth control. Yaz and Yasmin both contain drospirenone which may elevate the body’s potassium levels and has been associated with an increased risk of strokes.
Yaz and Yasmin consolidated litigation is in effect in Illinois, Pennsylvania, and New Jersey. Allegations set forth in Yaz and Yasmin lawsuits already filed in these states allege failure to warn on the part of Bayer, the manufacturer of both birth control pills. The FDA has issued warning letters to Bayer regarding the marketing of these birth control medications.
1-800-662-6230 or firstname.lastname@example.org
Latest posts by Holly Haines (see all)
- 1 in 20 Patients Harmed by Medical Errors, New Report Finds - August 1, 2019
- Errors in Electronic Health Records: A Growing Source forMedical Malpractice Claims - May 23, 2018
- User and System Failures: The Problems with Electronic Health Records - January 29, 2018